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Ecosinoids and blood vessel structure
We should, perhaps, pay more attention to the influence that ecosinoids have on
blood vessel behavior and structure, as substances such as nonsteroidal
antiinflammatory drugs (NSAIDs) and the so called selective cyclooxygenase 2
inhibitors are extensively employed by the population at large.
In this issue of Vascular Health and Risk Management, Claridge and colleagues
(2005) have reported a significant association of aortic wall stiffness with the use of
NSAIDs. This interesting finding  highlights the importance of the physiological
and pathophysiological effects of ecosinoids on blood vessel behavior and function,
as well as structure. The role of matrix metalloproteinase and plasminogen activator-
plasmin systems have been the subject of considerable investigation, and it is now
accepted that the remodeling of blood vessels is very much dependent upon
degradation of the extracellular matrix (Bobik and Tkachuk 2003). The prostanoid
that is thought to be involved in inducing the expression of metalloproteinase and
plaminogen activator is prostaglandin (PG) E2 (Khan et al 2004). Thus, the tendency
for increased stiffness of blood vessels as a consequence of NSAID use could possibly
result from a reduction in the levels of PG E2, perhaps in the vasculature.
Based on experiments employing isolated rat aortic rings, indomethacin treatment
in vitro produces a reduction in blood vessel compliances (Chin-Dusting et al 1988).
Moreover, in animals fed a supplement of fish oil, aortic compliance ex vivo appears
to be significantly reduced (Chin-Dusting et al 1988). In experimental animals, a
diet high in fish oil results in the lowering of some naturally occurring ecosinoids
(Hornstra et al 1981). Accordingly, it is possible that the reduction in biological
activities of certain prostanoids may manifest as a significant reduction in aortic
compliance ex vivo as observed in rats fed a high fish oil diet. This is not to suggest
that the use of fish oil will result in a decrease in vascular compliance in vivo, as this
issue remains controversial. However, whether, a similar mechanism is at play when
aortic stiffness is increased clinically following the use of NSAIDs remains to be
established. Certainly, the impact of NSAID use on blood vessel compliance needs a
closer and in-depth investigation in humans. While it would be interesting to further
pursue the notion of whether NSAIDs may also affect blood vessel stiffness in animals,
it would also be of great interest to delineate the molecular nature of this event in
experimental animals. Ultimately, the remodeling of blood vessels leading to altered
compliance will result in changes to hemodynamics, which may have a significant
impact on cardiac function. It is recognized that an increase in vascular stiffening
can significantly impact ventricular-arterial coupling that could eventually
compromise ventricular function (Kass 2002).
In a broader context, this is an interesting observation raising the issue as to
whether the use of NSAIDs is likely to increase adverse cardiovascular events and at
the same time beneficially retard aneurysm growth. Recently, there has been much
debate regarding cardiovascular risk (stroke and myocardial infarction, fatal and non-
fatal) associated with the use of selective cyclooxygenase 2 inhibitors (Tabrizchi
2005). However, more recently, it has also been suggested that the use of naproxen,
a non-selective inhibitor of the enzyme cyclooxygenase, also may pose an elevated
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cardiovascular risk (Boyles  2004). The evidence for the
latter suggestion is still quite limited and the increase in the
incidence of cardiovascular events may only be in patients
who have strong risk factors for heart attack and stroke
(Boyles  2004). Nonetheless, a pertinent question worth-
while considering is that the cardiovascular risk/benefit
associated with the inhibition of cyclooxygenase may not
be restricted to events such as thrombosis and vaso-
constriction, but may now have to be extended to alteration
in morphometry of the blood vessels.
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